Croft Associates have just launched a further manufacturing campaign for a significant tranche of 3979 LS Safkegs

Croft Associates have just launched a further manufacturing campaign for a significant tranche of 3979 LS Safkegs in response to further increased demand from our clients in the radiopharmaceutical industry.  These will supplement the more heavily shielded 3977 HS Safkegs already under manufacture within our NRC approved supply chain.  Both the LS and HS packages are now operated by numerous international radiopharmaceutical clients, particularly within areas of significant recent growth such as with respect to medical treatments utilising Mo-99 and Lu-177.